FDA Investigator James C Lee, PharmD

James C Lee, PharmD has inspections in 1 countries as of 14 Sep 2023. James C Lee, PharmD has collaborated with a combinined 2256 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
50
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alicia Gilbert, Alla Dubrovsky, Andrew B Slarve, Andrew Chang, Andrew E Kay, Andrew Tadros, Anh M Lac, Ann Marie Montemurro, Ann Marie Schofield, Anna L Marroquin, Annie H Lam, Ashar P Parikh, Baker, Blair, Breena L D'ambrogi, Brian R Henderson, Bruce D Broidy, Camacho, Capri R Woolridge, Carl Lee, Carr, CDR Rochelle B Young, RPh, MSA, Chloe Anne Leong, Christian D Lynch (CDL), Christopher R Czajka, Damon A Growl, Daniel J Roberts, Daniel Lagasse, Daniel Velasquez, David A Lum, David G Eng, Edna J Hidalgo, Elmina E Akwo, Elodie Xtong Lin, Emal Wahab, Emmanuel O Kerry, Eric J Heinze, Foley, Helen B Ricalde, Helen J Hamaoka, Ingrid A Zambrana, Ismael Garibay, Jacqueline Mdiaz Albertini, James C Yee, James G Marsh, Jeanmaire Hryshko, Jeanne A Young, Jeffrey M Watson, Jennifer Crumb, Jennifer L Johnson, Jennifer S King, Jessica B Darneille, Joan T Briones, John A Gonzalez, John A Liu, John Cook, Jolene S Hedgecock, Joseph George, Joseph Tibay, Josephine Valdemoro Chavez, Julie D Bringger, Karen D Phung, Karen J Bak, Kenneth S Boehnen, Kevin P Foley, Lance M De Souza, MBA, LCDR Jennifer H Rhyu, Lea Lakes, Lee, Leongc, Linda Linh T Nguyen, Linda Thai, Lourdes Andujar, Lucila B Nwatu, Lynda L Perry, PhD, Mabel M Lee, Macropolk, Maida Henesian (NMI), Makia P Dove, Margo Cl Jones, Maridali De Leon Torres, Mariza M Jafary, Mark E Chan, Marshalette O Edwards, Mary C Wall, Megan E Kulas, Mei Chiung J Huang, Melody M Ragasa Leong, Mihaly S Ligmond, Monique C Lo, Nancy E Kirschbaum, Nancy T Waites, Nicole Yuen, Omotunde O Osunsanmi, Patrick E Gainer, Paula A Trost, Peter E Baker, Phung, Prabhu P Raju, Quynh H Strandberg, Ralph A Erickson, Ravi S Harapanhalli, Raymond T Oji, Richard W Thornton, Riley C Graham, Robert W Jennings, Robles, Roman Drews, PhD, Roman T Drews, PhD, Ronald P Boyce, Rumany C Penn, PharmD, Samuel J Barone, III, Sandra S Saniga, Savannah E Samp, Scott N Lim, Sergio Chavez (NMI), Simone E Pitts, Siobhan A Gallagher, State Agency, Stephanie A Slater, MS, Steven B Chiu, Steven M Galvez, Susan M Jackson, Terrence Gee, Thomas N Adjabeng, Timothy C Grome, Travelle D Mason, Uduak M Inokon, Vi T Au, Victoria L Morgan, Vijaya L Simhadri, Walden H Lee, Wayne L Jefferson, Wendy S Shenk, William J Weis, Zuben E Sauna, PhD

James C Lee, PharmD's Documents

Publish Date Document Type Title
December, 2016 FDA 483 Bayer HealthCare LLC - Form 483, 2016-12-13

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more